BCM
Buckhead Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,487
| Closed | -$2.78M | – | 129 |
|
|
2025
Q1 | $2.78M | Sell |
18,487
-662
| -3% | -$99.6K | 0.89% | 46 |
|
|
2024
Q4 | $3.53M | Sell |
19,149
-1,961
| -9% | -$362K | 1.13% | 40 |
|
|
2024
Q3 | $4.16M | Sell |
21,110
-221
| -1% | -$43.5K | 1.31% | 30 |
|
|
2024
Q2 | $4.41M | Buy |
21,331
+779
| +4% | +$161K | 1.49% | 26 |
|
|
2024
Q1 | $5.57M | Buy |
20,552
+409
| +2% | +$111K | 1.88% | 13 |
|
|
2023
Q4 | $4.76M | Buy |
20,143
+901
| +5% | +$213K | 1.76% | 16 |
|
|
2023
Q3 | $3.77M | Buy |
19,242
+1,820
| +10% | +$357K | 1.57% | 25 |
|
|
2023
Q2 | $3.66M | Sell |
17,422
-2,667
| -13% | -$561K | 0.87% | 41 |
|
|
2023
Q1 | $4.05M | Buy |
20,089
+1,703
| +9% | +$344K | 0.95% | 40 |
|
|
2022
Q4 | $4.01M | Buy |
18,386
+4,698
| +34% | +$1.02M | 0.97% | 42 |
|
|
2022
Q3 | $2.69M | Buy |
13,688
+6,438
| +89% | +$1.27M | 0.7% | 50 |
|
|
2022
Q2 | $1.55M | Buy |
+7,250
| New | +$1.55M | 0.38% | 71 |
|